Characterization of 5' end of human thromboxane receptor gene. Organizational analysis and mapping of protein kinase C--responsive elements regulating expression in platelets.

Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction. To determine if platelet thromboxane receptors are under transcriptional control, we isolated and characterized human genomic DNA clones containing the 5' flanking region of the thromboxane receptor gene. The exon-intron structure of the 5' portion of the thromboxane receptor gene was determined initially by comparing the nucleotide sequence of the 5' flanking genomic clone with that of a novel human uterine thromboxane receptor cDNA that extended the mRNA 141 bp further upstream than the previously identified human placental cDNA. A major transcription initiation site was located in three human tissues approximately 560 bp upstream from the translation initiation codon and 380 bp upstream from any previously identified transcription initiation site. The thromboxane receptor gene has neither a TATA nor a CAAT consensus site. Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/chloramphenicol acetyltransferase (CAT) chimera plasmids into platelet-like K562 cells. Thromboxane receptor promoter activity, as assessed by CAT expression, was relatively weak but was significantly enhanced by phorbol ester treatment. Functional analysis of 5' deletion constructs in transfected K562 cells and gel mobility shift localized the major phorbol ester-responsive motifs in the thromboxane receptor gene promoter to a cluster of activator protein-2 (AP-2) binding consensus sites located approximately 1.8 kb 5' from the transcription initiation site. These studies are the first to determine the structure and organization of the 5' end of the thromboxane receptor gene and demonstrate that thromboxane receptor gene expression can be regulated by activation of protein kinase C via induction of an AP-2-like nuclear factor binding to upstream promoter elements. These findings strongly suggest that the mechanism for previously described upregulation of platelet thromboxane receptors after acute myocardial infarction is increased thromboxane receptor gene transcription in platelet-progenitor cells.

[1]  G. Dorn,et al.  Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells. , 1994, The Journal of pharmacology and experimental therapeutics.

[2]  K. Kent,et al.  Additions and Corrections to Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. , 1994, The Journal of Biological Chemistry.

[3]  G. Dorn,et al.  Gene expression during phorbol ester-induced differentiation of cultured human megakaryoblastic cells. , 1994, The American journal of physiology.

[4]  G. Schultz,et al.  G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. L. Le Breton,et al.  Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors. , 1993, The Journal of biological chemistry.

[6]  S. Narumiya,et al.  Characterization and chromosomal mapping of the human thromboxane A2 receptor gene. , 1993, The Journal of biological chemistry.

[7]  G. Dorn,et al.  Differential megakaryocytic desensitization to platelet agonists. , 1992, The American journal of physiology.

[8]  G. Dorn,et al.  Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cells. , 1992, The Journal of pharmacology and experimental therapeutics.

[9]  G. Dorn.  Regulation of response to thromboxane A2 in CHRF-288 megakaryocytic cells. , 1992, The American journal of physiology.

[10]  M. Klüppel,et al.  Reporter constructs with low background activity utilizing the cat gene. , 1992, Gene.

[11]  G. Dorn.  Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells. , 1991, The Journal of pharmacology and experimental therapeutics.

[12]  A. Shenker,et al.  The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. , 1991, Transactions of the Association of American Physicians.

[13]  R. Tjian,et al.  Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. , 1991, Science.

[14]  S. Nakanishi,et al.  Cloning and expression of cDNA for a human thromboxane A2 receptor , 1991, Nature.

[15]  M. Caron,et al.  Adrenergic receptors. Models for regulation of signal transduction processes. , 1990, Hypertension.

[16]  S. Narumiya,et al.  Expression of thromboxane A2 receptor in cultured human erythroleukemia cells and its induction by 12-O-tetradecanoylphorbol-13-acetate. , 1989, Biochemical and biophysical research communications.

[17]  M. Chao,et al.  A constitutive promoter directs expression of the nerve growth factor receptor gene. , 1988, Molecular and cellular biology.

[18]  D. Loh,et al.  A conserved sequence in the T-cell receptor beta-chain promoter region. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Karin,et al.  Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP , 1987, Cell.

[20]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[21]  M. Hamberg,et al.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Dorn,et al.  Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction. , 1990, Circulation.